Literature DB >> 4724587

Multiple N-acetyltransferases and drug metabolism. Tissue distribution, characterization and significance of mammalian N-acetyltransferase.

D J Hearse, W W Weber.   

Abstract

Investigations in the rabbit have indicated the existence of more than one N-acetyltransferase (EC 2.3.1.5). At least two enzymes, possibly isoenzymes, were partially characterized. The enzymes differed in their tissue distribution, substrate specificity, stability and pH characteristics. One of the enzymes was primarily associated with liver and gut and catalysed the acetylation of a wide range of drugs and foreign compounds, e.g. isoniazid, p-aminobenzoic acid, sulphamethazine and sulphadiazine. The activity of this enzyme corresponded to the well-characterized polymorphic trait of isoniazid acetylation, and determined whether individuals were classified as either ;rapid' or ;slow' acetylators. Another enzyme activity found in extrahepatic tissues readily catalysed the acetylation of p-aminobenzoic acid but was much less active towards isoniazid and sulphamethazine. The activity of this enzyme remained relatively constant from individual to individual. Studies in vitro and in vivo with both ;rapid' and ;slow' acetylator rabbits revealed that, for certain substrates, extrahepatic N-acetyltransferase contributes significantly to the total acetylating capacity of the individual. The possible significance and applicability of these findings to drug metabolism and acetylation polymorphism in man is discussed.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4724587      PMCID: PMC1177616          DOI: 10.1042/bj1320519

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  12 in total

1.  INVESTIGATION OF THE GENETIC CONTROL OF SULFADIAZINE AND ISONIAZID METABOLISM IN THE RABBIT.

Authors:  J W FRYMOYER; R F JACOX
Journal:  J Lab Clin Med       Date:  1963-12

2.  STUDIES OF GENETICALLY CONTROLLED SULFADIAZINE ACETYLATION IN RABBIT LIVERS: POSSIBLE IDENTIFICATION OF THE HETEROZYGOUS TRAIT.

Authors:  J W FRYMOYER; R F JACOX
Journal:  J Lab Clin Med       Date:  1963-12

3.  THE INFLUENCE OF ACETYLATOR PHENOTYPE ON THE EFFECTS OF TREATING DEPRESSION WITH PHENELZINE.

Authors:  D A EVANS; K DAVISON; R T PRATT
Journal:  Clin Pharmacol Ther       Date:  1965 Jul-Aug       Impact factor: 6.875

4.  A study of the renal clearances, metabolic inactivation rates, and serum fall-off interaction of isoniazid and paraminosalicylic acid in man.

Authors:  J W JENNE; F M MACDONALD; E MENDOZA
Journal:  Am Rev Respir Dis       Date:  1961-09

5.  Genetic control of isoniazid metabolism in man.

Authors:  D A EVANS; K A MANLEY; V A McKUSICK
Journal:  Br Med J       Date:  1960-08-13

Review 6.  PHARMACOGENETICS.

Authors:  A G MOTULSKY
Journal:  Prog Med Genet       Date:  1964

7.  Metabolism of isoniazid in man as related to the occurrence of peripheral neuritis.

Authors:  H B HUGHES; J P BIEHL; A P JONES; L H SCHMIDT
Journal:  Am Rev Tuberc       Date:  1954-08

8.  The polymorphic acetylation of sulphapyridine in man.

Authors:  H Schröder; D A Evans
Journal:  J Med Genet       Date:  1972-06       Impact factor: 6.318

9.  The actylation of sulamethazine and sulfamethoxypyridazine by human subjects.

Authors:  T A White; D A Evans
Journal:  Clin Pharmacol Ther       Date:  1968 Jan-Feb       Impact factor: 6.875

10.  Peripheral neuritis due to isoniazid.

Authors:  S DEVADATTA; P R GANGADHARAM; R H ANDREWS; W FOX; C V RAMAKRISHNAN; J B SELKON; S VELU
Journal:  Bull World Health Organ       Date:  1960       Impact factor: 9.408

View more
  27 in total

1.  Acetylation of S-substituted cysteines by a rat liver and kidney microsomal N-acetyltransferase.

Authors:  R M Green; J S Elce
Journal:  Biochem J       Date:  1975-05       Impact factor: 3.857

2.  Clinical pharmacokinetics of hydrallazine.

Authors:  T Talseth
Journal:  Clin Pharmacokinet       Date:  1977 Sep-Oct       Impact factor: 6.447

3.  N-acetylation of p-amino-hippurate in kidneys with renal artery stenosis and in patients suffering from severe essential hypertension.

Authors:  J Girndt; M Mályusz; K W Rumpf; F Scheler
Journal:  Klin Wochenschr       Date:  1974-10-01

4.  A filter paper method for determining isoniazid acetylator phenotype.

Authors:  W W Weber; W Brenner
Journal:  Am J Hum Genet       Date:  1974-07       Impact factor: 11.025

5.  Distribution of acetylator phenotype in relation to age and sex in Swedish patients. A retrospective study.

Authors:  O Paulsen; L G Nilsson
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

6.  Relationship between the genetically determined acetylator phenotype and DNA damage induced by hydralazine and 2-aminofluorene in cultured rabbit hepatocytes.

Authors:  C A McQueen; C J Maslansky; I B Glowinski; S B Crescenzi; W W Weber; G M Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1982-02       Impact factor: 11.205

7.  Bm-iAANAT3: Expression and characterization of a novel arylalkylamine N-acyltransferase from Bombyx mori.

Authors:  Matthew R Battistini; Brian G O'Flynn; Christopher Shoji; Gabriela Suarez; Lamar C Galloway; David J Merkler
Journal:  Arch Biochem Biophys       Date:  2018-11-16       Impact factor: 4.013

8.  Studies on hydralazine. II. Elimination rate and steady-state concentration in patients with impaired renal function.

Authors:  T Talseth
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953

9.  N-acetylation of drugs. Observations on the properties of partially purified N-acetyltransferase from peripheral blood of rabbit.

Authors:  G S Drummond; H C Kelker; W W Weber
Journal:  Biochem J       Date:  1980-04-01       Impact factor: 3.857

10.  Acute murine colitis reduces colonic 5-aminosalicylic acid metabolism by regulation of N-acetyltransferase-2.

Authors:  Verónica Ramírez-Alcántara; Marshall H Montrose
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2014-04-17       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.